Quark Venture Inc., a Vancouver, Canada-based venture capital investment firm, appointed Karimah Es Sabar as Chief Executive Officer and Partner.
Ms. Es Sabar, who most recently led the Centre for Drug Research and Development as President & CEO, and before that, Life Sciences BC, has an expansive global career spanning multi-national pharmaceutical/biotechnology companies, startups, not-for-profit organizations and venture investment.
She will help the firm launch the Global Health Sciences Venture Fund.
Established in 2015 by Jesson Chen, Chairman and Partner, Quark Venture provides equity financing to innovative biotechnology and health sciences companies with innovative technology platforms and projects.
Partners in the Global Health Sciences Venture Fund include investment banks and institutional investors, with GF Securities as lead strategic fund partner.